Fatal, gold-induced pneumonitis
We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and p...
Gespeichert in:
Veröffentlicht in: | Rheumatology international 2003-07, Vol.23 (4), p.207-210 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 210 |
---|---|
container_issue | 4 |
container_start_page | 207 |
container_title | Rheumatology international |
container_volume | 23 |
creator | SOLER, M. Jose BARROSO, Encarnacion ARANDA, F. Ignacio ALONSO, Sergio ROMERO, Santiago |
description | We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and prompt discontinuation of the drug is emphasised. |
doi_str_mv | 10.1007/s00296-003-0293-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_884136251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2695617347</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-4e63060c7a16d729b97133717b11f0b66f656dda2348044b7a7513ffdca923573</originalsourceid><addsrcrecordid>eNp1kE1LAzEQhoMotlZ_gBctijejM0k2H0cpVoWCFwVvIZvsypbtbt3sHvz3pnShJy-ZDDzzDvMQconwgADqMQIwIykAp-nDqTgiUxRcUZTwdUymgIpRnZ4JOYtxDamXEk7JBJnOJAozJddL17v6fv7d1oFWTRh8Eebbphg2bVP1VTwnJ6WrY3Ex1hn5XD5_LF7p6v3lbfG0op5r1lNRSA4SvHIog2ImNwo5V6hyxBJyKUuZyRAc40KDELlyKkNelsE7w3im-Izc7HO3XfszFLG363bomrTSai2QS5b4Gbn9D2LSpIsUF7so3FO-a2PsitJuu2rjul-LYHfe7N6bTd7szpsVaeZqTB7yTREOE6OoBNyNgIve1WXnGl_FAyeMFjrd_AfjvXEf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2695617347</pqid></control><display><type>article</type><title>Fatal, gold-induced pneumonitis</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>SOLER, M. Jose ; BARROSO, Encarnacion ; ARANDA, F. Ignacio ; ALONSO, Sergio ; ROMERO, Santiago</creator><creatorcontrib>SOLER, M. Jose ; BARROSO, Encarnacion ; ARANDA, F. Ignacio ; ALONSO, Sergio ; ROMERO, Santiago</creatorcontrib><description>We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and prompt discontinuation of the drug is emphasised.</description><identifier>ISSN: 0172-8172</identifier><identifier>EISSN: 1437-160X</identifier><identifier>DOI: 10.1007/s00296-003-0293-4</identifier><identifier>PMID: 12856149</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Aged ; Antirheumatic Agents - adverse effects ; Arthritis, Rheumatoid - drug therapy ; Biological and medical sciences ; Fatal Outcome ; Female ; Gold Sodium Thiomalate - adverse effects ; Humans ; Lung Diseases, Interstitial - chemically induced ; Medical sciences</subject><ispartof>Rheumatology international, 2003-07, Vol.23 (4), p.207-210</ispartof><rights>2003 INIST-CNRS</rights><rights>Springer-Verlag 2003.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-4e63060c7a16d729b97133717b11f0b66f656dda2348044b7a7513ffdca923573</citedby><cites>FETCH-LOGICAL-c382t-4e63060c7a16d729b97133717b11f0b66f656dda2348044b7a7513ffdca923573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14984871$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12856149$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SOLER, M. Jose</creatorcontrib><creatorcontrib>BARROSO, Encarnacion</creatorcontrib><creatorcontrib>ARANDA, F. Ignacio</creatorcontrib><creatorcontrib>ALONSO, Sergio</creatorcontrib><creatorcontrib>ROMERO, Santiago</creatorcontrib><title>Fatal, gold-induced pneumonitis</title><title>Rheumatology international</title><addtitle>Rheumatol Int</addtitle><description>We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and prompt discontinuation of the drug is emphasised.</description><subject>Aged</subject><subject>Antirheumatic Agents - adverse effects</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Biological and medical sciences</subject><subject>Fatal Outcome</subject><subject>Female</subject><subject>Gold Sodium Thiomalate - adverse effects</subject><subject>Humans</subject><subject>Lung Diseases, Interstitial - chemically induced</subject><subject>Medical sciences</subject><issn>0172-8172</issn><issn>1437-160X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kE1LAzEQhoMotlZ_gBctijejM0k2H0cpVoWCFwVvIZvsypbtbt3sHvz3pnShJy-ZDDzzDvMQconwgADqMQIwIykAp-nDqTgiUxRcUZTwdUymgIpRnZ4JOYtxDamXEk7JBJnOJAozJddL17v6fv7d1oFWTRh8Eebbphg2bVP1VTwnJ6WrY3Ex1hn5XD5_LF7p6v3lbfG0op5r1lNRSA4SvHIog2ImNwo5V6hyxBJyKUuZyRAc40KDELlyKkNelsE7w3im-Izc7HO3XfszFLG363bomrTSai2QS5b4Gbn9D2LSpIsUF7so3FO-a2PsitJuu2rjul-LYHfe7N6bTd7szpsVaeZqTB7yTREOE6OoBNyNgIve1WXnGl_FAyeMFjrd_AfjvXEf</recordid><startdate>20030701</startdate><enddate>20030701</enddate><creator>SOLER, M. Jose</creator><creator>BARROSO, Encarnacion</creator><creator>ARANDA, F. Ignacio</creator><creator>ALONSO, Sergio</creator><creator>ROMERO, Santiago</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope></search><sort><creationdate>20030701</creationdate><title>Fatal, gold-induced pneumonitis</title><author>SOLER, M. Jose ; BARROSO, Encarnacion ; ARANDA, F. Ignacio ; ALONSO, Sergio ; ROMERO, Santiago</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-4e63060c7a16d729b97133717b11f0b66f656dda2348044b7a7513ffdca923573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>Antirheumatic Agents - adverse effects</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Biological and medical sciences</topic><topic>Fatal Outcome</topic><topic>Female</topic><topic>Gold Sodium Thiomalate - adverse effects</topic><topic>Humans</topic><topic>Lung Diseases, Interstitial - chemically induced</topic><topic>Medical sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SOLER, M. Jose</creatorcontrib><creatorcontrib>BARROSO, Encarnacion</creatorcontrib><creatorcontrib>ARANDA, F. Ignacio</creatorcontrib><creatorcontrib>ALONSO, Sergio</creatorcontrib><creatorcontrib>ROMERO, Santiago</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><jtitle>Rheumatology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SOLER, M. Jose</au><au>BARROSO, Encarnacion</au><au>ARANDA, F. Ignacio</au><au>ALONSO, Sergio</au><au>ROMERO, Santiago</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fatal, gold-induced pneumonitis</atitle><jtitle>Rheumatology international</jtitle><addtitle>Rheumatol Int</addtitle><date>2003-07-01</date><risdate>2003</risdate><volume>23</volume><issue>4</issue><spage>207</spage><epage>210</epage><pages>207-210</pages><issn>0172-8172</issn><eissn>1437-160X</eissn><abstract>We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and prompt discontinuation of the drug is emphasised.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>12856149</pmid><doi>10.1007/s00296-003-0293-4</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0172-8172 |
ispartof | Rheumatology international, 2003-07, Vol.23 (4), p.207-210 |
issn | 0172-8172 1437-160X |
language | eng |
recordid | cdi_proquest_journals_884136251 |
source | MEDLINE; SpringerLink Journals |
subjects | Aged Antirheumatic Agents - adverse effects Arthritis, Rheumatoid - drug therapy Biological and medical sciences Fatal Outcome Female Gold Sodium Thiomalate - adverse effects Humans Lung Diseases, Interstitial - chemically induced Medical sciences |
title | Fatal, gold-induced pneumonitis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T05%3A29%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fatal,%20gold-induced%20pneumonitis&rft.jtitle=Rheumatology%20international&rft.au=SOLER,%20M.%20Jose&rft.date=2003-07-01&rft.volume=23&rft.issue=4&rft.spage=207&rft.epage=210&rft.pages=207-210&rft.issn=0172-8172&rft.eissn=1437-160X&rft_id=info:doi/10.1007/s00296-003-0293-4&rft_dat=%3Cproquest_cross%3E2695617347%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2695617347&rft_id=info:pmid/12856149&rfr_iscdi=true |